Page last updated: 2024-08-26

fibrinogen and Cancer of Prostate

fibrinogen has been researched along with Cancer of Prostate in 69 studies

Research

Studies (69)

Timeframe	Studies, this research(%)	All Research%
pre-1990	35 (50.72)	18.7374
1990's	5 (7.25)	18.2507
2000's	9 (13.04)	29.6817
2010's	16 (23.19)	24.3611
2020's	4 (5.80)	2.80

Authors

Authors	Studies
Sun, J; Yan, L	1
Deng, Z; Hu, Y; Jiang, T; Lei, X; Yang, N; Zhang, T	1
Huang, YH; Li, G; Li, JH; Li, Y; Pu, JX; Xie, GS; Yin, HM	1
Aasen, T; Abdul Moin, NI; Abdul Wafi, S; Aboukameel, A; Abu-Bakar, N; Acharya, A; Ackermans, L; Adaramoye, O; Adarsh, KV; Adeosun, WA; Ahmad, NH; Ahmadi, F; Akanni, O; Akbar, M; Akbulak, RO; Akev, N; Akkaya, Ö; Al-Rashed, S; AlAbbad, S; Alabi, O; Alappat, BJ; Alcalá, S; Alcoutlabi, M; Aleppo, G; Alexander Ross, JB; Alexander, JH; Alexander, R; Alias, A; Alimba, C; Alken, FA; Allan, R; Alpers, M; Alsbou, EM; Amarasiri, SS; An, T; Anastasiadis, F; Anastassiadou, M; Anderson, KC; Andronikos, P; Anheyer, D; Annapurna, K; Anorlu, RI; Anten, MM; Anthopoulos, TD; Araujo-Castillo, RV; Aravamudhan, S; Arawwawala, LDAM; Arulsamy, N; Arunamata, A; Asghar, A; Asiri, AM; Aslanidou, T; Astrakhantseva, IV; Astutik, E; Attanayake, AP; Atwater, BD; Audureau, E; Augusto, S; Bakare, A; Banach, M; Bandelier, P; Banerjee, S; Barral, M; Bascuñán, J; Bates, FS; Bauer, NJC; Bayrak, BB; Beck, RW; Beckervordersantforth, J; Beeri, R; Begum, R; Beldi-Ferchiou, A; Bellingham, G; Ben-Tal, N; Bendib, I; Bergenstal, RM; Berger, MF; Bernasconi, G; Berry, S; Beuvon, F; Bi, WJ; Bi, Z; Bianconi, V; Bibi, I; Blank, BR; Bliemeister, E; Bobkowski, W; Bode, AM; Booth, CM; Bose, U; Boyd, K; Brancato, A; Brenmoehl, J; Brogi, E; Bronzo, P; Brooks, T; Brown, D; Brown, DN; Bruce, D; Buan, MEM; Bueno-Hernández, F; Bugielski, B; Bulavaitė, A; Buscagan, TM; Buxton, R; Caffaro, MM; Cai, Q; Cai, X; Cai, Y; Calhoun, P; Callander, N; Cambier, S; Camparo, P; Canales-Vargas, EJ; Canham, K; Cantu, J; Cao, J; Cao, JW; Cao, P; Cao, T; Cao, X; Caravella, BA; Carcadea, E; Carè, J; Carmichael, P; Carrasco Cabrera, L; Carteaux, G; Carvalho, PDS; Casarez, E; Cazorla, M; Celestrin, CP; Chakraborty, NK; Chan, B; Chandarlapaty, S; Chandgude, AL; Chang, CC; Chang, JH; Chang, X; Chang, Y; Chankhanittha, T; Chantanis, S; Chapovetsky, A; Chavan, S; Chen, B; Chen, D; Chen, F; Chen, G; Chen, H; Chen, J; Chen, K; Chen, KJ; Chen, KP; Chen, L; Chen, MA; Chen, Q; Chen, S; Chen, W; Chen, WF; Chen, X; Chen, Y; Cheng, D; Cheng, J; Cheng, Q; Cheon, GJ; Chiu, SC; Cho, CH; Cho, J; Choi, H; Choi, JS; Choi, YH; Christie, P; Chu, CH; Chu, Y; Chung, DH; Chung, F; Cline, JP; Cohen, A; Cohen, AD; Cohen, NJ; Comen, E; Compter, I; Cong, J; Cong, Z; Cooper, A; Cornud, F; Costa, C; Costa, S; Covey, A; Cowan, AM; Cramer, H; Cruz-Rivera, C; Cui, J; Cui, M; Cui, Y; Cui, YH; Culquichicón, C; Cushman, T; D'Auria, SJ; da Silva, J; Dalgediene, I; Danenberg, HD; Das, S; Dasgupta, K; Daubit, IM; de Oliveira, PD; de Prost, N; De Ruysscher, D; Dearman, K; Decato, D; Delfau-Larue, MH; Deng, L; Dhakate, SR; Dharuman, V; Di Costanzo, N; Dickler, MN; Dinehart, EE; Ding, D; Dinh, TK; Divya, KP; Djifack Tadongfack, T; Do, T; Domínguez-Roldan, R; Domínguez-Zambrano, E; Dömling, A; Donato, MD; Dong, JH; Dong, W; Dong, X; Dong, XR; Dong, Y; Dong, Z; Downs, M; Drutskaya, MS; Du, B; Du, F; Du, H; Du, L; Du, X; Duan, Z; Duangthip, D; Dunstand-Guzmán, E; Duong, F; Eckert, DJ; Edelhäuser, BAH; Eekers, DBP; Efendi, F; Efraimidis, P; Ehrenberg, H; Ehsanbakhsh, Z; Eickholt, C; Eksterowicz, J; El Mobadder, M; El-Araby, IE; El-Magd, MA; El-Tarabany, MS; Elgorban, AM; Engelmann, D; English, KL; Esfandiari, H; Eslami, B; Espinosa-Cuevas, A; Eswara, S; Faber, E; Fan, XH; Fan, Y; Fang, J; Fang, Z; Fantin, VR; Fei, P; Feng, G; Feng, H; Feng, J; Feng, X; Feng, XJ; Fennell, TR; Fernández-Moreira, V; Ferraz, ABF; Ferreras, KN; Flores, K; Flores-Pérez, I; Flox, C; Fluharty, FL; Fokouong Tchoffo, E; Folefack, GO; Foroutan, T; Fort, D; Fourati, S; Fousas, S; Frapard, T; Freguia, S; Friedman, DJ; Friedman, LS; Fu, D; Fu, Q; Fu, Y; Fujinami, S; Furihata, K; Gal, RL; Gan, H; Gao, C; Gao, F; Gao, R; Gao, SS; Gao, W; Gao, XC; Gao, Y; Gao, Z; Garozi, L; Ge, J; Georgiopoulos, A; Gerakiou, K; Ghazimirsaeed, SM; Ghazimirsaeed, ST; Gimeno, MC; Gjestad, R; Glurich, I; Goetchius, E; Goland, S; Goldstein, S; Gonçalves, CM; Gonçalves, H; Gong, Q; Gonzalez, D; Goplen, FK; Gorshkova, EN; Gotsman, I; Govindasamy, V; Granger, CB; Greco, L; Grigoriadou-Skouta, E; Grigoropoulos, P; Grivicich, I; Gromov, NV; Gruber, S; Grytczuk, M; Grzech-Leśniak, K; Gu, L; Gu, S; Gu, Z; Guadagnini, D; Guan, H; Guilliams, M; Guo, J; Guo, L; Gupta, A; Gupta, SK; Gurzu, S; Gutleb, AC; Haban, A; Hablitz, JJ; Hadisuyatmana, S; Hahn, S; Haiges, R; Hallal-Calleros, C; Hamed, M; Hammad, N; Hammer, N; Han, C; Hao, Y; Harnett, J; Has, EMM; Hassanpour, K; Hatzopoulos, D; Hawaldar, R; He, X; He, Y; He, YY; He, Z; Heberman, D; Heckl, D; Hegde, H; Henson, MA; Hernández-Velázquez, VM; Herrera, E; Hijazi, Z; Hirayama, K; Hirth, JM; Hoeben, A; Hohnloser, SH; Hong, M; Hood, K; Hoplock, LB; Hopman, WM; Horlbogen, LM; Hossein Rashidi, B; Hou, G; Hou, H; Hou, J; Hou, Y; Hu, J; Hu, W; Hu, X; Hua, W; Huang, G; Huang, H; Huang, J; Huang, T; Huang, W; Huang, Y; Huang, YD; Huang, Z; Hudis, CA; Hue, S; Huo, J; Hussain, M; Hvas, AM; Ichii, T; Ide Zeuna, J; Ilyas, S; Inoue, T; Iranzo, A; Irfan, M; Iwasa, Y; Iwashita, Y; Izgorodina, EI; J R, A; Jaber, WA; Jaborek, JR; Jacobus, SJ; Jadeja, SD; Jafarabadi, M; Jalan, D; Jamil, MI; Jarrah, S; Jarvis, D; Jayatilaka, KAPW; Jemal-Turki, A; Jeon, YK; Jeong, N; Jeong, SH; Jeong, SY; Jermy, M; Jhaveri, K; Ji, H; Ji, K; Ji, RY; Jiang, F; Jiang, J; Jiang, X; Jiang, Y; Jiao, Q; Jilani, K; Jiménez-Guerrero, P; Jin, L; Jo, YH; Johnson, JG; Johnson, ML; Jones, WS; Jose, S; Jularic, M; Jung, I; Jung, YJ; Jungen, C; Junttila, MR; Kache, S; Kahanovitch, U; Kalantzi, KI; Kallio, T; Kamnoedboon, P; Kang, CH; Kang, H; Kang, J; Kang, KW; Kapoor, P; Karmakar, D; Kartalis, A; Kauranen, P; Kazocina, A; Keikha, F; Keltai, M; Kershaw, SV; Kettani, M; Khalvati, S; Khandhar, S; Khosla, N; Kiely, CJ; Kim, CC; Kim, H; Kim, MJ; Kim, Y; Kim, YH; Kim, YT; Kimoto, E; Kiyu, A; Klatt, N; Kobayashi, M; Koh, J; Köhler, R; Kondadasula, SV; Kong, H; Kong, W; Kong, X; Kotidis, A; Kotwal, A; Kouvari, M; Kozhinov, AN; Kruger, D; Kuang, S; Kuang, Y; Kubota, M; Kuklik, P; Kumar, P; Kumar, SK; Kuo, YF; Kurup, SP; Kusuhara, H; Kuswanto, H; Lacouture, ME; Lambin, P; Lang, CC; Langroudi, FH; Lanman, RB; Larsen, OH; Laskin, J; Le, VH; Leach, M; Lee, BG; Lee, DF; Lee, DS; Lee, HJ; Lee, SB; Lee, YA; Lei, Y; Lekashvili, O; Lelj, F; Lemin, AS; Lemoine, J; Leuschner, R; Li, B; Li, BT; Li, C; Li, D; Li, F; Li, G; Li, H; Li, HW; Li, J; Li, M; Li, P; Li, Q; Li, S; Li, W; Li, X; Li, XY; Li, Y; Li, Z; Lian, Y; Liang, C; Liao, J; Liao, W; Liao, Y; Lin, D; Lin, W; Lin, YL; Lindbäck, J; Lindsay, AP; Ling, J; Linser, PJ; Liu, C; Liu, H; Liu, JJ; Liu, L; Liu, Q; Liu, SF; Liu, X; Liu, Y; Liu, Z; Liu, ZM; Lo Sterzo, C; Lo, ECM; Lobchuk, MM; Lodge, TP; Logotheti, S; Lonial, S; Lopes, G; Lopes, RD; Lopez, J; Lopez, SA; López-Santos, AL; López-Sendón, JL; Loring, Z; Louis, C; Lovita, AND; Lu, DZ; Lu, H; Lu, J; Lu, K; Lu, TT; Lu, Y; Luengo, A; Lum, LG; Luna, JM; Luo, L; Luo, R; Luo, T; Luo, X; Luo, Z; Lv, B; Lymperopoulos, N; Lyras, A; Lyu, Y; M Kannan, A; Ma, H; Ma, M; Ma, Q; Ma, S; Ma, WY; Ma, Y; Maalouf, E; Machado, FA; Maeda, K; Magrans, JO; Maharani, A; Maia, G; Mainwaring, RD; Maji, TK; Majumdar, K; Mannarino, MR; Mansuri, MS; Marinescu, SC; Markatos, G; Marquardt, S; Marraiki, N; Martens, C; Martínez, TJ; Marumo, K; Maruyama, H; Marwani, HM; Marzo, I; Masrati, G; Matamba, P; Mathialagan, S; Matys, J; Mayatra, JM; Mboua, PC; McArthur, T; McCrimmon, RJ; McIntosh, S; McSpadden, S; Medina-Campos, ON; Medvedovsky, AT; Mei, Z; Mekontso-Dessap, A; Menezes, AMB; Meng, J; Meng, P; Meng, Y; Menter, A; Mets, MB; Mets-Halgrimson, R; Metzger, T; Metzler-Nolte, N; Meyer, C; Mi, Y; Michailoviene, V; Mikrogeorgiou, A; Militz, H; Miller Iii, TF; Minarowska, A; Mir, S; Miron, I; Miyake, T; Moayer, F; Modi, S; Moeller, SJ; Mohamad, MN; Mohammed, EHM; Mokhonov, VV; Mondal, A; Moore, J; Moravcova, M; Mordi, IR; Mordi, NA; Mortensen, NP; Moscariello, C; Moser, J; Moynahan, ME; Mu, J; Mu, W; Mudduwa, LKB; Mukherjee, S; Mukhtar, A; Mulkey, DK; Murr, N; Mushtaq, Z; Muthuswamy, N; Mutlu, O; Muto, C; Myroforou, I; Na, KJ; Nabi, M; Nagornov, KO; Nagy, RJ; Naik, A; Nakajima, K; Nam, KT; Nam, YW; Namburath, M; Nammour, S; Namour, A; Namour, M; Nanan, S; Natsume, H; Nave, S; Naveed, A; Nazir, H; Ndubaku, C; Nedospasov, SA; Neradilek, MB; Newcomb, C; Nguépy Keubo, FR; Nguyen, M; Ning, J; Ning, Q; Noguchi, S; Nordahl, SHG; Nordfalk, KF; Norton, L; Noupoue, EM; Nouri, SS; Nowak, JK; Núñez, K; Oakes, K; Odegaard, JI; Ogorodnikova, OL; Ogunsuyi, O; Oh, HK; Oh, HR; Oh, KH; Ohgi, K; Okunade, KS; Oliveira, AG; Olorunfemi, G; Olsen, ML; Olson, BA; Omari, KW; Ondruschka, B; Orfali, R; Orkopoulos, A; Orlowski, RZ; Oser, SM; Oser, TK; Özcan, M; Padilla, V; Paeng, JC; Pajuelo-Lozano, N; Pal, SK; Palmieri, S; Palomeque, E; Pan, W; Panagiotakos, DB; Pandey, M; Pang, D; Pang, Q; Pangarah, CA; Panny, A; Paparella, A; Papirio, S; Papouskova, K; Parang, K; Park, HJ; Park, IK; Park, S; Parker, TL; Parkhomenko, A; Parmon, VN; Parsons, B; Parsons, J; Patel, PR; Patil, S; Patsourakos, NG; Patterson, KC; Pavlidis, P; Pedernera, M; Pedersen, R; Pedraza-Chaverri, J; Pellegrini, M; Peña-Chora, G; Pereira, EDM; Pereira, MADS; Peretz, A; Perez-Padilla, R; Perlman, GY; Perona, R; Petras, C; Phuntsho, S; Picada, JN; Pinder, TA; Piper, LFJ; Pirozzi, F; Pirro, M; Pleckaityte, M; Ploutz-Snyder, LL; Ploutz-Snyder, R; Pogorzelski, A; Poles, L; Postma, AA; Prager, A; Prakash, J; Punn, R; Pützer, BM; Qi, J; Qi, MC; Qi, Y; Qian, J; Qian, Y; Qiang, L; Qiu, J; Qu, Y; Rabiu, KA; Rahighi, S; Rahman, MM; Rahmani, B; Rajkumar, SV; Ramanathan, R; Raras, TYM; Rashi, Y; Rasool, G; Rathore, MG; Ratnawati, R; Ratola, N; Raucci, U; Ray, SK; Razavi, P; Razazi, K; Razek, S; Razi, SS; Reback, M; Reddy, K; Rees, DC; Reginatto, FH; Reich, H; Reis-Filho, JS; Ren, X; Ren, Y; Renner, G; Rey, G; Reymen, B; Riaz, M; Ricci, A; Richardson, PG; Richter, C; Riga, M; Ritchie, C; Rivoal, S; Roberts, W; Robson, ME; Rocha, GZ; Rodrigues, AD; Rogach, AL; Rojas, A; Rosenberg, A; Rosenberg, E; Rosenheck, RA; Roslan, K; Rothenberger, C; Rouschop, KMA; Rubagumya, F; Ryan, CM; Ryder, JW; Saad, MJA; Sacan, O; Sacchi, A; Sahebkar, A; Saini, A; Sainz, B; Sajo, EA; Sakizadeh, J; Saleh, AA; Salgado Júnior, IB; Salvi, R; Samoylova, YV; Samuni, A; Sanchez, DM; Sanchez-Perez, I; Santos, M; Sarapulova, A; Sardot, T; Saud, N; Sauerbier, P; Scaltriti, M; Schaeffer, B; Schalk, DL; Scherschel, K; Schijven, MP; Schreuder, HWR; Schuhmacher, M; Schultz-Lebahn, A; Schwarzl, J; Scott, JM; Sebayang, SK; Seeger, ZL; Segabinazi Peserico, C; Selenica, P; Serio, A; Seruga, B; Shah, A; Shah, C; Shah, PD; Shahrokh Tehraninezhad, E; Shan, A; Shao, Z; Sharma, AMR; Sharma, RK; Shen, J; Shen, R; Shi, X; Shi, Y; Shi, ZE; Shih, YC; Shimohata, H; Shimpi, N; Shin, SH; Shon, HK; Shuvy, M; Siddique, AB; Siegbahn, A; Sikandar, M; Silvani, Y; Singh, A; Singh, AK; Singh, D; Singh, JS; Singh, KP; Singh, M; Situ, B; Skipper, MT; Skouloudi, M; Sloane, BF; Smyrnioudis, N; Snyder, MA; Söhnchen, C; Solis Condor, R; Solit, DB; Someya, S; Song, H; Song, J; Song, W; Song, Y; Sorokina, KN; Soshi, S; Soyer, P; Spitschak, A; Sreekrishnan, TR; Srinivasan, M; Staruschenko, A; Steel, A; Stefan-van Staden, RI; Stein, AM; Strayer, H; Struthers, AD; Su, H; Su, Q; Su, X; Sudore, RL; Sugimura, H; Sugiyama, Y; Sujuti, H; Sumner, SJ; Sun, B; Sun, D; Sun, H; Sun, J; Sun, JY; Sun, X; Sun, Y; Sun, Z; Sung, YC; Surenaud, M; Sutimantanapi, D; Suwandaratne, NS; Swaroop, S; Sychrova, H; Syed, A; Szczepanik, M; Szederjesi, J; Szodorai, R; Tacy, TA; Tadelle, RM; Takayasu, M; Tammeveski, K; Tan, H; Tan, M; Tang, HX; Tang, S; Tang, X; Tanokura, M; Tao, F; Tao, H; Tarafdari, A; Tarín-Carrasco, P; Tasson Tatang, C; Teixeira, JP; Thakur, A; Theobald, A; Thevenot, P; Thomaidis, K; Tian, J; Tillib, SV; Toma, C; Tomita, M; Tonchev, I; Tong, F; Toy, W; Trypuć, M; Tselepis, AD; Tsetseris, L; Tsikouri, GE; Tsikouris, EI; Tsoplifack, CB; Tsoumani, ME; Tsujimoto, R; Tsybin, YO; Tu, J; Tu, TM; Turco, M; Turkyilmaz, IB; Uddin, MJ; Ung, J; Unsihuay, D; Utsunomiya, T; Vagenende, B; Vaishnav, J; Valdes, C; Validad, MH; Valle, J; van Ginkel, MPH; van Grevenstein, WMU; Vanderpuye, V; Vasan, N; Vasilenko, EA; Vasques, GJ; Vavoulis, P; Verani, A; Veziroglu, E; Viegas, A; Vitali, MG; Vitsas, G; Voccio, JP; Vogiatzidis, C; Volow, A; Volpin, F; Vourvahis, M; Wagner, LI; Walkowiak, J; Wallace, R; Wallentin, L; Wan, D; Wan, L; Wan, T; Wang, C; Wang, F; Wang, FN; Wang, H; Wang, J; Wang, L; Wang, Q; Wang, S; Wang, T; Wang, W; Wang, X; Wang, XW; Wang, Y; Wang, YS; Wang, Z; Ward, J; Ward, L; Waseem, R; Watson, DF; Weber, P; Wehrmeister, FC; Wei, CH; Wei, H; Wei, L; Wei, Q; Wei, Y; Weinstock, RS; Weiss, M; Welborn, M; Wen, L; Wen, LM; Wen, Q; Wen, Z; Wesseling, P; Westerbergh, J; White, K; Wick, MP; Willems, S; Wiyasa, IWA; Wójciak, R; Wolkenhauer, O; Won, HH; Wong, J; Woo, YC; Wood, LS; Wu, CT; Wu, CY; Wu, D; Wu, G; Wu, J; Wu, K; Wu, M; Wu, Q; Wu, T; Wu, W; Wu, X; Wu, XT; Wu, Y; Xi, D; Xi, J; Xiang, W; Xiang, Y; Xiao, M; Xiao, Z; Xie, H; Xie, Q; Xie, S; Xie, X; Xing, M; Xing, YL; Xu, C; Xu, X; Xu, Y; Xu, Z; Xue, F; Xue, XD; Yaglioglu, HG; Yamada, H; Yamashita, M; Yan, W; Yan, Z; Yanardag, R; Yang, D; Yang, H; Yang, K; Yang, QQ; Yang, R; Yang, S; Yang, T; Yang, X; Yang, Y; Yao, H; Yao, Y; Yari, D; Yassin, MT; Ye, C; Ye, J; Ye, Q; Yildiz, EA; Ying, S; Yoon, H; Yu, D; Yu, K; Yu, N; Yu, PL; Yuan, C; Yuan, D; Yuan, LJ; Yuan, Z; Yuen, N; Zagatto, AM; Zakaria, Y; Zalewski, AM; Zamora, S; Zavorotinskaya, T; Zeid, JL; Zeinoun, T; Zeng, C; Zerby, HN; Zhan, X; Zhang, A; Zhang, D; Zhang, E; Zhang, F; Zhang, H; Zhang, J; Zhang, L; Zhang, M; Zhang, P; Zhang, Q; Zhang, QY; Zhang, RG; Zhang, S; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, CK; Zhao, H; Zhao, J; Zhao, K; Zhao, Q; Zhao, S; Zhao, T; Zhao, XQ; Zhao, Y; Zhao, Z; Zheng, J; Zheng, L; Zheng, Y; Zhou, B; Zhou, G; Zhou, L; Zhou, T; Zhou, X; Zhu, C; Zhu, J; Zhu, Y; Zhu, ZQ; Zhuang, T; Zimmermannova, O; Zin, NNINM; Zisimos, K; Zoghebi, KA; Zonder, JA; Zou, C; Zwirner, J	1
Wang, FM; Xing, NZ	1
Cvetković, Z; Kulić, A; Libek, V	1
Buelens, S; Decaestecker, K; Lumen, N; Poelaert, F; Van Huele, A; Van Praet, C	1
Bugert, P; Graf, ME; Hoffmeister, M; Johnson, T; Kaaks, R; Katzke, V; Kühn, T; Maldonado, SG; Pletsch-Borba, L; Schübel, R; Sookthai, D	1
Cho, NH; Cho, SY; Choi, YD; Kang, S; Kim, DS; Kim, YJ; Na, HJ	1
Awsiuk, K; Bernasik, A; Budkowski, A; Lekka, M; Lukes, J; Madej, E; Pabijan, J; Prauzner-Bechcicki, S; Raczkowska, J; Rysz, J; Sepitka, J	1
Gerger, A; Kapp, KS; Krenn-Pilko, S; Langsenlehner, T; Langsenlehner, U; Pichler, M; Stojakovic, T; Thurner, EM	1
Binkovsky, N; Cherny, I; Inbal, A; Lederfein, D; Rabizadeh, E; Rosenblat, Y; Sherman, S	1
Brite, J; Dowd, JB; McCrillis, AM; Reales, D; Romo, ML; Schooling, CM	1
Bagoly, Z	1
Cai, Y; Dong, B; Huang, J; Huang, Y; Liu, Q; Pan, J; Sha, J; Shao, X; Wang, Y; Wang, Z; Xu, F; Xue, W; Yin, W; Zhu, Y	1
Musch, M	1
Carmignani, G; Esposito, M; Simonato, A; Varca, V; Venzano, F	1
Godoy, A; Gray, DR; Mohler, JL; Montecinos, VP; Singh, S; Smith, GJ; Sotomayor, P; Vethanayagam, RR; Yau, JM	1
Li, S	1
Chennazhi, KP; Jayakumar, R; Muthunarayanan, M; Nair, SV; Rejinold, NS	1
Breza, J; Goncalves, FM; Ziaran, S	1
Batta, Z; Benyo, M; Flasko, T; Harsfalvi, J; Jozsa, T; Kerenyi, A; Molnar, Z	1
Bayer, E; Gelbmann, D; Gerner, C; Peter, B; Posovszky, C; Schulte-Hermann, R; Vejda, S; Zelzer, S	1
CRANE, JJ; HAMILTON, J; WARE, AG	2
FRICK, PG	1
BOROS, M; RAK, K; TARNOKY, K; VERECZKEY, C	1
ALLEN, TD	1
SAMAMA, M	1
SHARP, AA	1
BUCHBERGER, HG; KRUEGER, J; PIPER, W; SIMON, S	1
Ayhan, S; Ermete, M; Işisağ, A; Kandiloğlu, AR; Lekili, M; Neşe, N	1
Silvestri, AR; Zucchelli, P	1
Blann, AD; Caine, GJ; Lip, GY; Ryan, P	1
Francis, CW; Sahni, A; Sahni, SK; Simpson-Haidaris, PJ; Vaday, GG	1
Haidar, A; Saad, F; Shabsigh, R; Yassin, A	1
MARDER, M; WEINER, M	1
Blix, S	1
Becopoulos, T; Dimopoulos, C; Kranides, A; Louizou, K; Mandalaki-Yianitsiotis, T; Panagiotopoulou, E	1
Aiginger, P; Kuzmits, R; Schwarz, HP	1
Dubey, GK; Gupta, VL; Raichur, BS; Saoji, AM	1
Binder, BR; Kohno, I; Okabe, H; Okajima, K; Soe, G; Takatsuki, K	1
Chiang, HS; Huang, TF; Swaim, MW	1
Gagnon, GA; Sallah, S	1
Deutsch, E	1
Byar, DP; Corle, DK; Doe, RP; Seal, US	2
Blombäck, M; Edsmyr, F; Kockum, C; Paul, C	1
Kaliski, D; Langkopf, B	1
Binder, BR; Kohno, I; Okabe, H; Okajima, K; Takatsuki, K; Tsuruta, J	1
Kisiel, W; Kudryk, BJ; Memoli, VA; Moritz, TE; Rousseau, SM; Stump, DC; Wojtukiewicz, MZ; Zacharski, LR	1
Blombäck, M; Carlström, K; Eriksson, A; Henriksson, P; Stege, R	1
Blombäck, M; Bratt, G; Edhag, O; Eriksson, A; Henriksson, P; Vesterqvist, O	1
Al-Mondhiry, H; Bartholomew, MJ; Drago, J	1
Edgington, TS; Plow, EF	1
Astedt, B; Carlsson, S	1
Fry, GL; Hoak, JC; Jacobsen, CD; Wu, KK	1
Alkjaersig, N; Fisher, S; Fletcher, AP; Sherry, S	1
Guseĭnov, ChS; Petrov, LA; Rakhmaeva, VA; Vantsian, EN	1
Bowie, EJ; Owen, CA	1
Carlsson, S	1
Braun, HJ; Hiller, E	1
Gormsen, J	1
Honi, S; Inaoka, Y; Ishibashi, K; Kawagoe, H	1
Alfrey, CP; Gross, JB; Lynch, EC; Natelson, EA	1
Lasch, HG	1
Brooks, MB	1
Aggeler, PM; Friedman, NJ; Hoag, MS; Robinson, AJ	1
Consorti, P; Gennari, C	1

Reviews

6 review(s) available for fibrinogen and Cancer of Prostate

Article	Year
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors. Annales medico-psychologiques, 2021, Volume: 179, Issue:2 Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses	2021
Pharmacologic androgen deprivation and cardiovascular disease risk factors: a systematic review. European journal of clinical investigation, 2015, Volume: 45, Issue:5 Topics: Adiposity; Androgen Antagonists; Antineoplastic Agents, Hormonal; Blood Glucose; Blood Pressure; C-Reactive Protein; Cardiovascular Diseases; Diabetes Mellitus; Dyslipidemias; Fibrinogen; Humans; Hypertension; Insulin Resistance; Male; Prostatic Neoplasms; Risk Factors; Triglycerides	2015
[THE PHYSIOPATHOLOGY OF FIBRINOLYSIS AND ITS CLINICAL AND THERAPEUTIC APPLICATIONS]. Transfusion, 1964, Volume: 7 Topics: Blood Transfusion; Enzyme Inhibitors; Female; Fibrin; Fibrinogen; Fibrinolysin; Fibrinolysis; Hemostatics; Humans; Leukemia; Liver Cirrhosis; Male; Pathology; Physiology; Polycythemia Vera; Pregnancy; Pregnancy Complications; Pregnancy Complications, Hematologic; Prostatectomy; Prostatic Neoplasms; Prothrombin; Thrombin; Thromboplastin	1964
PATHOLOGICAL FIBRINOLYSIS. British medical bulletin, 1964, Volume: 20 Topics: Aminocaproates; Aminocaproic Acid; Anticoagulants; Blood Coagulation Disorders; Blood Group Incompatibility; Deoxyribonuclease I; Drug Therapy; Female; Fibrinogen; Fibrinolysis; Heart, Artificial; Hematoma; Hematoma, Subdural; Humans; Leukemia; Liver Cirrhosis; Male; Menorrhagia; Peritoneum; Pleura; Postoperative Complications; Pregnancy; Pregnancy Complications; Prostatic Neoplasms; Snake Bites; Streptodornase and Streptokinase; Streptokinase; Thrombocytopenia; Urogenital System; Wounds and Injuries	1964
[Hemostatic system in cancer patients]. Voprosy onkologii, 1972, Volume: 18, Issue:7 Topics: Animals; Blood Coagulation; Fibrinogen; Fibrinolysis; Humans; Male; Neoplasms; Pancreatic Neoplasms; Platelet Adhesiveness; Prostatic Neoplasms; Rats; Stomach Neoplasms	1972
Chronic intravascular coagulation syndromes. A summary. Mayo Clinic proceedings, 1974, Volume: 49, Issue:9 Topics: Blood Coagulation; Bone Marrow; Chronic Disease; Disseminated Intravascular Coagulation; Fibrin; Fibrinogen; Humans; Liver; Lung Neoplasms; Male; Prostatic Neoplasms; Surgical Procedures, Operative	1974

Trials

6 trial(s) available for fibrinogen and Cancer of Prostate

Article	Year
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors. Annales medico-psychologiques, 2021, Volume: 179, Issue:2 Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses	2021
Prospective Randomized Controlled Trial Exploring the Effect of TachoSil on Lymphocele Formation After Extended Pelvic Lymph Node Dissection in Prostate Cancer. Urology, 2018, Volume: 118 Topics: Aged; Drug Combinations; Fibrinogen; Humans; Lymph Node Excision; Lymphatic Metastasis; Lymphocele; Male; Middle Aged; Postoperative Complications; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Thrombin	2018
The use of a surgical patch in the prevention of lymphoceles after extraperitoneal pelvic lymphadenectomy for prostate cancer: a randomized prospective pilot study. The Journal of urology, 2009, Volume: 182, Issue:5 Topics: Drug Combinations; Fibrinogen; Humans; Lymph Node Excision; Lymphocele; Male; Middle Aged; Pilot Projects; Prospective Studies; Prostatic Neoplasms; Single-Blind Method; Surgical Sponges; Thrombin	2009
Reversion of primary hyperfibrinogenolysis in patients with hormone-refractory prostate cancer using docetaxel. Cancer investigation, 2000, Volume: 18, Issue:3 Topics: Aged; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Docetaxel; Drug Resistance, Neoplasm; Fibrinogen; Fibrinolysis; Hemorrhage; Humans; Male; Neoplasm Metastasis; Paclitaxel; Prostate-Specific Antigen; Prostatic Neoplasms; Taxoids; Urokinase-Type Plasminogen Activator	2000
Response of plasma fibrinogen and plasminogen to hormone treatment and the relation of pretreatment values to mortality in patients with prostatic cancer. Cancer, 1976, Volume: 38, Issue:3 Topics: Age Factors; Body Weight; Clinical Trials as Topic; Diethylstilbestrol; Dose-Response Relationship, Drug; Estrogens, Conjugated (USP); Fibrinogen; Humans; Male; Medroxyprogesterone; Plasminogen; Prostatic Neoplasms	1976
Effects of oestrogen therapy and orchidectomy on coagulation and prostanoid synthesis in patients with prostatic cancer. Medical oncology and tumor pharmacotherapy, 1989, Volume: 6, Issue:3 Topics: Aged; Antigens; Blood Coagulation Disorders; Data Interpretation, Statistical; Epoprostenol; Estradiol; Ethinyl Estradiol; Exercise Test; Factor VII; Fibrinogen; Fibrinolysis; Humans; Male; Orchiectomy; Prospective Studies; Prostatic Neoplasms; Random Allocation; Thromboxane A2; Time Factors	1989

Other Studies

58 other study(ies) available for fibrinogen and Cancer of Prostate

Article	Year
The diagnostic effectiveness of serum sialic acid predicts both qualitative and quantitative prostate cancer in patients with prostate-specific antigen between 4 and 20 ng/mL. Frontiers in endocrinology, 2023, Volume: 14 Topics: Alkaline Phosphatase; Fibrinogen; Humans; Male; N-Acetylneuraminic Acid; Prostate-Specific Antigen; Prostatic Neoplasms; Retrospective Studies	2023
Coagulation markers as independent predictors of prostate cancer aggressiveness: a retrospective cohort study. Scientific reports, 2023, 09-26, Volume: 13, Issue:1 Topics: Blood Coagulation; Fibrinogen; Hemostatics; Humans; Male; Prostatic Neoplasms; Retrospective Studies	2023
Clinical association between pre-treatment levels of plasma fibrinogen and bone metastatic burden in newly diagnosed prostate cancer patients. Chinese medical journal, 2019, Nov-20, Volume: 132, Issue:22 Topics: Aged; Bone Neoplasms; Female; Fibrinogen; Humans; Logistic Models; Male; Neoplasm Grading; Prostate-Specific Antigen; Prostatic Neoplasms; Retrospective Studies	2019
Systemic Coagulation Markers Especially Fibrinogen Are Closely Associated with the Aggressiveness of Prostate Cancer in Patients Who Underwent Transrectal Ultrasound-Guided Prostate Biopsy. Disease markers, 2021, Volume: 2021 Topics: Aged; Biomarkers, Tumor; Blood Coagulation; Endoscopic Ultrasound-Guided Fine Needle Aspiration; Fibrinogen; Humans; Male; Middle Aged; Prostatic Neoplasms	2021
Primary hyperfibrinolysis as the presenting sign of prostate cancer: A case report. Vojnosanitetski pregled, 2016, Volume: 73, Issue:9 Topics: Adenocarcinoma; Antifibrinolytic Agents; Biomarkers; Blood Coagulation Disorders; Blood Coagulation Tests; Bone Neoplasms; Factor VIII; Fibrinogen; Fibrinolysis; Hematoma; Hemorrhage; Humans; Male; Middle Aged; Paraneoplastic Syndromes; Prostatic Neoplasms; Tranexamic Acid; Treatment Outcome	2016
Pre-diagnostic plasma concentrations of Fibrinogen, sGPIIb/IIIa, sP-selectin, sThrombomodulin, Thrombopoietin in relation to cancer risk: Findings from a large prospective study. International journal of cancer, 2018, 12-01, Volume: 143, Issue:11 Topics: Adult; Autoantigens; Biomarkers, Tumor; Breast Neoplasms; CD36 Antigens; Colorectal Neoplasms; Female; Fibrinogen; Humans; Iodide Peroxidase; Iron-Binding Proteins; Male; Middle Aged; P-Selectin; Prospective Studies; Prostatic Neoplasms; Risk Factors; Thrombomodulin	2018
HSP27, ALDH6A1 and Prohibitin Act as a Trio-biomarker to Predict Survival in Late Metastatic Prostate Cancer. Anticancer research, 2018, Volume: 38, Issue:11 Topics: Aldehyde Oxidoreductases; alpha 1-Antitrypsin; Biomarkers, Tumor; Chaperonin 60; Fibrinogen; Gene Expression Regulation, Neoplastic; Heat-Shock Proteins; HSP27 Heat-Shock Proteins; Humans; Male; Methylmalonate-Semialdehyde Dehydrogenase (Acylating); Mitochondrial Proteins; Molecular Chaperones; Neoplasm Metastasis; Prognosis; Prohibitins; Prostatic Neoplasms; Proteomics; Repressor Proteins; Survival Analysis; Up-Regulation	2018
PDMS substrate stiffness affects the morphology and growth profiles of cancerous prostate and melanoma cells. Journal of the mechanical behavior of biomedical materials, 2015, Volume: 41 Topics: Biomechanical Phenomena; Cell Line, Tumor; Cell Proliferation; Dimethylpolysiloxanes; Elasticity; Fibrinogen; Humans; Male; Mechanical Phenomena; Melanoma; Microchip Analytical Procedures; Prostatic Neoplasms; Surface Properties	2015
The association of an elevated plasma fibrinogen level with cancer-specific and overall survival in prostate cancer patients. World journal of urology, 2015, Volume: 33, Issue:10 Topics: Aged; Austria; Biomarkers, Tumor; Disease Progression; Disease-Free Survival; Fibrinogen; Follow-Up Studies; Humans; Male; Prognosis; Proportional Hazards Models; Prostatic Neoplasms; Radiotherapy, Conformal; Retrospective Studies; ROC Curve; Survival Rate	2015
The cell-membrane prothrombinase, fibrinogen-like protein 2, promotes angiogenesis and tumor development. Thrombosis research, 2015, Volume: 136, Issue:1 Topics: Animals; Carcinogenesis; Cell Line, Tumor; Cell Proliferation; Fibrinogen; Human Umbilical Vein Endothelial Cells; Humans; Male; MAP Kinase Signaling System; Mice, SCID; Neovascularization, Pathologic; Prostate; Prostatic Neoplasms; RNA Interference; RNA, Small Interfering; Thrombin; Thromboplastin	2015
Cancer and thrombosis: a fresh look at an old story. Thrombosis research, 2015, Volume: 136, Issue:1 Topics: Animals; Carcinogenesis; Fibrinogen; Humans; Male; MAP Kinase Signaling System; Neovascularization, Pathologic; Prostatic Neoplasms; Thromboplastin	2015
Pretreatment plasma fibrinogen as an independent prognostic indicator of prostate cancer patients treated with androgen deprivation therapy. Prostate cancer and prostatic diseases, 2016, Volume: 19, Issue:2 Topics: Aged; Androgen Antagonists; Biomarkers, Tumor; Combined Modality Therapy; Disease Progression; Fibrinogen; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Male; Neoplasm Grading; Neoplasm Staging; Prognosis; Prostatic Neoplasms; ROC Curve	2016
Editorial comment. The Journal of urology, 2009, Volume: 182, Issue:5 Topics: Drug Combinations; Fibrinogen; Humans; Lymph Node Excision; Lymphocele; Male; Prostatic Neoplasms; Surgical Sponges; Thrombin	2009
Androgen deprivation induces rapid involution and recovery of human prostate vasculature. American journal of physiology. Endocrinology and metabolism, 2011, Volume: 300, Issue:2 Topics: Androgens; Angiogenic Proteins; Animals; Capillaries; Cells, Cultured; Fibrinogen; Humans; Image Processing, Computer-Assisted; Immunocompromised Host; Immunohistochemistry; Intercellular Signaling Peptides and Proteins; Male; Mice; Mice, SCID; Microscopy, Confocal; Middle Aged; Neoplasm Transplantation; Prostate; Prostatic Neoplasms; Regional Blood Flow; Reverse Transcriptase Polymerase Chain Reaction; Testosterone; Vascular Endothelial Growth Factor A	2011
Gingival bleeding as a presenting sign of primary fibrinogenolysis. Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics, 2011, Volume: 112, Issue:1 Topics: Carcinoma; Diagnosis, Differential; Fibrin Fibrinogen Degradation Products; Fibrinogen; Gingival Hemorrhage; Humans; Male; Middle Aged; Prostatic Neoplasms	2011
Curcumin loaded fibrinogen nanoparticles for cancer drug delivery. Journal of biomedical nanotechnology, 2011, Volume: 7, Issue:4 Topics: Animals; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Line; Cell Line, Tumor; Curcumin; Drug Delivery Systems; Female; Fibrinogen; Hemolysis; Humans; In Vitro Techniques; Male; Materials Testing; Mice; Nanocapsules; Nanotechnology; Particle Size; Prostatic Neoplasms	2011
Patients with prostate cancer treated by ADT have significantly higher fibrinogenemia than healthy control. World journal of urology, 2013, Volume: 31, Issue:2 Topics: Aged; Androgen Antagonists; Antineoplastic Agents, Hormonal; Blood Glucose; C-Reactive Protein; Cardiovascular Diseases; Case-Control Studies; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mellitus, Type 2; Fibrinogen; Gonadotropin-Releasing Hormone; Humans; Insulin Resistance; Male; Middle Aged; Prospective Studies; Prostatic Neoplasms; Testosterone; Triglycerides	2013
Follow-up of thrombin generation after prostate cancer surgery: global test for increased hypercoagulability. PloS one, 2012, Volume: 7, Issue:12 Topics: Aged; Blood Cell Count; Body Mass Index; Fibrinogen; Follow-Up Studies; Hemostasis; Humans; Male; Middle Aged; Postoperative Period; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms; Statistics, Nonparametric; Thrombin; Thrombophilia	2012
Plasma from cancer patients featuring a characteristic protein composition mediates protection against apoptosis. Molecular & cellular proteomics : MCP, 2002, Volume: 1, Issue:5 Topics: alpha-2-Antiplasmin; Apoptosis; Blotting, Western; Breast Neoplasms; Caspase 8; Caspase 9; Caspases; Dimerization; Electrophoresis, Polyacrylamide Gel; fas Receptor; Female; Fibrinogen; Humans; Jurkat Cells; Laminin; Lung Neoplasms; Male; Mass Spectrometry; Neoplasms; Precipitin Tests; Prostatic Neoplasms; Signal Transduction; Ultraviolet Rays	2002
Spontaneous afibrinogenemia in cancer of prostate: report of two cases. Transactions. American Urological Association. Western Section, 1954, Volume: 21 Topics: Afibrinogenemia; Fibrinogen; Hemorrhagic Disorders; Humans; Male; Neoplasms; Prostatic Neoplasms	1954
Spontaneous afibrinogenemia in cancer of prostate; report of two cases. The Journal of urology, 1955, Volume: 73, Issue:2 Topics: Afibrinogenemia; Fibrinogen; Hemorrhagic Disorders; Humans; Male; Neoplasms; Prostatic Neoplasms	1955
Acute hemorrhagic syndrome with hypofibrinogenemia in metastatic cancer. Acta haematologica, 1956, Volume: 16, Issue:1 Topics: Afibrinogenemia; Fibrinogen; Hemorrhagic Disorders; Humans; Male; Neoplasms; Pancreatic Neoplasms; Prostatic Neoplasms; Stomach; Stomach Neoplasms	1956
[Cryofibrinogenemia and pathologically increased fibrinolysis a patient with prostate cancer]. Zeitschrift fur klinische Medizin, 1962, Volume: 157 Topics: Cryoglobulinemia; Fibrinogen; Fibrinolysis; Hemostatics; Humans; Male; Prostatic Neoplasms	1962
DISORDERS OF COAGULATION ASSOCIATED WITH SURGERY OF THE PROSTATE. Texas state journal of medicine, 1964, Volume: 60 Topics: Blood Coagulation Disorders; Blood Transfusion; Diethylstilbestrol; Estrogens; Fibrinogen; Fibrinolysis; Geriatrics; Hematuria; Hemorrhagic Disorders; Humans; Infusions, Parenteral; Male; Physiology; Prostatectomy; Prostatic Neoplasms	1964
[FIBRINOLYSIS AND ANTIFIBRINOLYTIC THERAPY IN UROLOGIC OPERATIONS. EXAMINATIONS USING A NEW METHOD FOR MEASURING FIBRINOLYSIS]. Die Medizinische Welt, 1965, Feb-20, Volume: 60 Topics: Aminocaproates; Aminocaproic Acid; Antifibrinolytic Agents; Aprotinin; Drug Therapy; Fibrin; Fibrinogen; Fibrinolysin; Fibrinolysis; Humans; Male; Prostatectomy; Prostatic Hyperplasia; Prostatic Neoplasms; Surgical Procedures, Operative; Trypsin Inhibitors; Urologic Diseases	1965
Col IV and Fn distribution in prostatic adenocarcinoma and correlation of 67LR, MMP-9 and TIMP-1 expression with Gleason score. Analytical and quantitative cytology and histology, 2003, Volume: 25, Issue:5 Topics: Adenocarcinoma; Aged; Aged, 80 and over; Basement Membrane; Case-Control Studies; Collagen Type IV; Extracellular Matrix Proteins; Fibrinogen; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Male; Matrix Metalloproteinase 9; Middle Aged; Neoplasm Proteins; Prostatic Hyperplasia; Prostatic Neoplasms; Receptors, Laminin; Severity of Illness Index; Tissue Inhibitor of Metalloproteinase-1	2003
Production and use of fibrin glue at blood transfusion service of Bellaria-Maggiore Hospital Bologna. Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis, 2004, Volume: 30, Issue:2 Topics: Aged; Blood Transfusion; Case-Control Studies; Fibrin Tissue Adhesive; Fibrinogen; Hemorrhage; Hemostatics; Hospitals; Humans; Italy; Male; Middle Aged; Prostatectomy; Prostatic Neoplasms; Retrospective Studies; Thrombin; Tissue Adhesives; Urology; Wound Healing	2004
Significant decrease in angiopoietin-1 and angiopoietin-2 after radical prostatectomy in prostate cancer patients. Cancer letters, 2007, Jun-28, Volume: 251, Issue:2 Topics: Aged; Angiopoietin-1; Angiopoietin-2; Biomarkers; Blood Coagulation; Fibrinogen; Humans; Male; Middle Aged; Neovascularization, Pathologic; P-Selectin; Platelet Activation; Prostatectomy; Prostatic Neoplasms; Receptors, Vascular Endothelial Growth Factor; Vascular Endothelial Growth Factor A; von Willebrand Factor	2007
Fibrinogen synthesized by cancer cells augments the proliferative effect of fibroblast growth factor-2 (FGF-2). Journal of thrombosis and haemostasis : JTH, 2008, Volume: 6, Issue:1 Topics: Cell Proliferation; Drug Synergism; Fibrinogen; Fibroblast Growth Factor 2; Humans; Lung Neoplasms; Male; Neoplasms; Prostatic Neoplasms; RNA, Small Interfering; Tumor Cells, Cultured	2008
Effects of androgen deprivation on glycaemic control and on cardiovascular biochemical risk factors in men with advanced prostate cancer with diabetes. The aging male : the official journal of the International Society for the Study of the Aging Male, 2007, Volume: 10, Issue:4 Topics: Adenocarcinoma; Aged; Aged, 80 and over; Blood Glucose; C-Reactive Protein; Cardiovascular Diseases; Cholesterol; Comorbidity; Diabetes Mellitus, Type 2; Fibrinogen; Glycated Hemoglobin; Gonadotropin-Releasing Hormone; Humans; Male; Middle Aged; Prostatic Neoplasms; Retrospective Studies; Risk Factors; Triglycerides	2007
Afibrinogenemia occurring in a case of malignancy of the prostate with bone metastases. New York state journal of medicine, 1949, May-15, Volume: 49, Issue:10 Topics: Afibrinogenemia; Blood; Bone and Bones; Bone Neoplasms; Fibrinogen; Humans; Male; Neoplasm Metastasis; Prostate; Prostatic Neoplasms	1949
Anticoagulant treatment of the defibrination syndrome. Acta medica Scandinavica, 1967, Volume: 181, Issue:5 Topics: Acid Phosphatase; Afibrinogenemia; Blood Coagulation Disorders; Blood Proteins; Bone Marrow Examination; Diethylstilbestrol; Factor V; Factor VIII; Fibrinogen; Humans; Male; Middle Aged; Prostatic Neoplasms; Warfarin	1967
[Disseminated intravascular coagulation syndrome (D.I.C.) and carcinoma of the prostate (author's transl)]. Journal d'urologie, 1980, Volume: 86, Issue:6 Topics: Adenoma; Aged; Carcinoma; Cold Temperature; Disseminated Intravascular Coagulation; Factor XIII; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Humans; Male; Middle Aged; Prostatic Hyperplasia; Prostatic Neoplasms	1980
[Proteinase inhibitors and fibrinogen split products in patients with malignant diseases (author's transl)]. Acta medica Austriaca, 1981, Volume: 8, Issue:1 Topics: alpha 1-Antitrypsin; alpha-Macroglobulins; Antifibrinolytic Agents; Antineoplastic Agents; Antithrombin III; Complement C1 Inactivator Proteins; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Male; Multiple Myeloma; Neoplasm Metastasis; Plasminogen; Prostatic Neoplasms; Rhabdomyosarcoma; Testicular Neoplasms	1981
Demonstration of MISFI (molecules immunologically similar to fibrinogen) and fibrinogen antibody in various pathological studies using counter immunoelectrophoresis. Indian journal of pathology & microbiology, 1983, Volume: 26, Issue:2 Topics: Anemia, Sickle Cell; Autoantibodies; Counterimmunoelectrophoresis; Fibrinogen; Humans; Leukemia, Myeloid, Acute; Male; Pancreatic Neoplasms; Prostatic Neoplasms	1983
Direct evidence for systemic fibrinogenolysis in patients with acquired alpha 2-plasmin inhibitor deficiency. American journal of hematology, 1994, Volume: 45, Issue:1 Topics: Adult; Aged; alpha-2-Antiplasmin; Aortic Aneurysm, Abdominal; Chromatography, Affinity; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Immunoblotting; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Prostatic Neoplasms; Stomach Neoplasms	1994
Characterisation of platelet aggregation induced by PC-3 human prostate adenocarcinoma cells and inhibited by venom peptides, trigramin and rhodostomin. European journal of cancer (Oxford, England : 1990), 1996, Volume: 32A, Issue:4 Topics: Adenocarcinoma; Antibodies, Monoclonal; Apyrase; Cysteine Proteinase Inhibitors; Fibrinogen; Glycoproteins; Hirudins; Humans; Intercellular Signaling Peptides and Proteins; Male; Peptides; Phospholipases A; Phospholipases A2; Platelet Aggregation; Platelet Aggregation Inhibitors; Prostatic Neoplasms; Thrombin; Tumor Cells, Cultured	1996
Disseminated intravascular coagulation in prostatic disease. Progress in clinical and biological research, 1976, Volume: 6 Topics: Adenocarcinoma; Adenocarcinoma, Bronchiolo-Alveolar; Aged; Blood Coagulation Factors; Blood Coagulation Tests; Disseminated Intravascular Coagulation; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Hemorrhage; Heparin; Humans; Male; Neoplasm Metastasis; Prostatectomy; Prostatic Hyperplasia; Prostatic Neoplasms	1976
Response of serum haptoglobin to hormone treatment and the relation of pretreatment values to mortality in patients with prostatic cancer. Cancer, 1978, Volume: 42, Issue:4 Topics: Aged; Diethylstilbestrol; Dose-Response Relationship, Drug; Estrogens; Estrogens, Conjugated (USP); Fibrinogen; Haptoglobins; Humans; Hydrocortisone; Male; Medroxyprogesterone; Middle Aged; Neoplasm Metastasis; Prognosis; Prostatic Neoplasms; Time Factors	1978
Blood coagulation studies in patients with advanced carcinoma of the prostate treated with 2,6-cis-diphenylhexamethylcyclotetrasiloxane or estramustine-17-phosphate. Urological research, 1978, Volume: 6, Issue:2 Topics: Afibrinogenemia; Aged; Antithrombins; Blood Coagulation; Estradiol Congeners; Estramustine; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Male; Middle Aged; Nitrogen Mustard Compounds; Prostatic Neoplasms; Prothrombin; Silicones; Siloxanes	1978
[Our experience with coagulopathies in urologic practice]. Zeitschrift fur Urologie und Nephrologie, 1975, Volume: 68, Issue:5 Topics: Adenocarcinoma; Adult; Aged; Blood Coagulation Disorders; Carcinoma; Female; Fibrinogen; Fibrinolysis; Genital Diseases, Female; Hematuria; Humans; Male; Middle Aged; Oliguria; Postoperative Complications; Prostatic Neoplasms; Shock; Shock, Septic	1975
Direct evidence for systemic fibrinogenolysis in a patient with metastatic prostatic cancer. Thrombosis research, 1992, Jun-15, Volume: 66, Issue:6 Topics: Aged; alpha-2-Antiplasmin; Antibodies, Monoclonal; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Immunoblotting; Immunohistochemistry; Male; Molecular Weight; Neoplasm Metastasis; Prostatic Neoplasms; Tissue Plasminogen Activator	1992
Fibrin formation on vessel walls in hyperplastic and malignant prostate tissue. Cancer, 1991, Mar-01, Volume: 67, Issue:5 Topics: Antibodies, Monoclonal; Endothelium, Vascular; Fibrin; Fibrinogen; Humans; Male; Molecular Weight; Plasminogen Activators; Prostatic Hyperplasia; Prostatic Neoplasms; Survival Rate; Thromboplastin; Warfarin	1991
Effect of parenteral oestrogen on the coagulation system in patients with prostatic carcinoma. British journal of urology, 1990, Volume: 65, Issue:3 Topics: Antithrombin III; Blood Coagulation Factors; Blood Proteins; Complement C1 Inactivator Proteins; Estradiol; Estradiol Congeners; Factor VII; Factor VIII; Fibrinogen; Humans; Injections, Intramuscular; Male; Plasminogen; Prostatic Neoplasms	1990
The fibrinolytic system in experimental prostate tumor. Thrombosis and haemostasis, 1986, Oct-21, Volume: 56, Issue:2 Topics: Animals; Fibrinogen; Fibrinolysis; Male; Plasminogen; Prostatic Neoplasms; Rats; Rats, Inbred Strains; Time Factors	1986
Discriminating neoantigenic differences between fibrinogen and fibrin derivatives. Proceedings of the National Academy of Sciences of the United States of America, 1973, Volume: 70, Issue:4 Topics: Abruptio Placentae; Acute Kidney Injury; Adenocarcinoma; Binding Sites, Antibody; Binding, Competitive; Blood Coagulation Disorders; Epitopes; Female; Fibrin; Fibrinogen; Fibrinolysin; Fibrinolysis; Humans; Immune Sera; Iodine Isotopes; Male; Melanoma; Meningococcal Infections; Peritonitis; Pregnancy; Prostatic Neoplasms; Radioimmunoassay; Structure-Activity Relationship	1973
Oestrogenic treatment of prostatic cancer lowers the fibrinolytic activity in vein walls. Scandinavian journal of urology and nephrology, 1974, Volume: 8, Issue:3 Topics: Alpha-Globulins; Antifibrinolytic Agents; Blood Coagulation; Blood Coagulation Factors; Depression, Chemical; Estrogens; Fibrin; Fibrinogen; Fibrinolysis; Humans; Macroglobulins; Male; Plasminogen; Prostatic Neoplasms; Time Factors; Veins	1974
Fibrinogen-fibrin-related antigen pattern in human blood. Differences between plasma and serum from pateints with disseminated intravascular coagulation. Thrombosis et diathesis haemorrhagica, 1974, Dec-31, Volume: 32, Issue:2-3 Topics: Adult; Aged; Antigens; Blood Coagulation; Disseminated Intravascular Coagulation; Female; Fibrin; Fibrinogen; Humans; Immunodiffusion; Immunoelectrophoresis; Leukemia, Myeloid; Male; Middle Aged; Plasma; Prostatic Neoplasms; Thrombin	1974
Immunoelectrophoretic characterization of plasma fibrinogen derivatives in patients with pathological plasma proteolysis. The Journal of laboratory and clinical medicine, 1967, Volume: 70, Issue:6 Topics: Acrylates; Agar; Aminocaproates; Animals; Blood Coagulation Disorders; Blood Coagulation Tests; Electrophoresis; Extracorporeal Circulation; Fibrinogen; Fibrinolysin; Fibrinolysis; Fibrinolytic Agents; Gels; Humans; Immune Sera; Immunoelectrophoresis; Liver Cirrhosis; Male; Molecular Weight; Nicotinic Acids; Plasma; Prostatic Neoplasms; Rabbits	1967
Fibrinogen degradation products in serum from patients with cancer. Acta chirurgica Scandinavica, 1973, Volume: 139, Issue:6 Topics: Aminocaproates; Blood Coagulation; Breast Neoplasms; Colonic Neoplasms; Female; Fibrin; Fibrinogen; Fibrinolysis; Gastrointestinal Neoplasms; Humans; Immunoelectrophoresis; Intestinal Neoplasms; Kidney Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Neoplasm Metastasis; Neoplasm Recurrence, Local; Pancreatic Neoplasms; Prostatic Neoplasms; Rectal Neoplasms; Thrombin; Urinary Bladder Neoplasms; Urogenital Neoplasms	1973
[Primary increase of fibrinolysis in a patient with metastatic carcinoma of the prostate (author's transl)]. Medizinische Klinik, 1974, Apr-26, Volume: 69, Issue:17 Topics: Afibrinogenemia; Aged; Aminocaproates; Antineoplastic Agents; Blood Platelets; Bone Neoplasms; Chlorotrianisene; Diagnosis, Differential; Disseminated Intravascular Coagulation; Ethinyl Estradiol; Fibrinogen; Fibrinolysis; Heparin; Humans; Male; Neoplasm Metastasis; Phosphoric Acids; Prostatic Neoplasms; Stilbenes	1974
Fibrinolytic activity and haemagglutination inhibition immunoassays. Scandinavian journal of haematology, 1970, Volume: 7, Issue:4 Topics: Adult; Aged; Biguanides; Clofibrate; Coronary Disease; Ethylestrenol; Female; Fibrin; Fibrinogen; Fibrinolysis; Hemagglutination Inhibition Tests; Hemostasis; Humans; Immunoassay; Immunodiffusion; Immunoelectrophoresis; Liver Cirrhosis; Male; Metformin; Middle Aged; Neoplasm Metastasis; Nicotinic Acids; Physical Exertion; Plasminogen; Prostatic Neoplasms; Stimulation, Chemical; Time Factors; Tolazamide	1970
[Improved standard fibrin plate method and development of methods for rapid analysis of fibrinogen-fibrin degradation products]. Rinsho byori. The Japanese journal of clinical pathology, 1971, Volume: 19 Topics: Blood Coagulation Tests; Female; Fibrinogen; Fibrinolysis; Humans; Leukemia, Myeloid; Male; Methods; Prostatic Neoplasms; Uterine Neoplasms	1971
Heparin-induced thrombocytopenia. An unexpected response to treatment of consumption coagulopathy. Annals of internal medicine, 1969, Volume: 71, Issue:6 Topics: Aged; Blood Cell Count; Blood Coagulation Disorders; Blood Platelets; Fibrinogen; Heparin; Humans; Male; Prostatic Neoplasms; Thrombocytopenia	1969
[Clinical aspects and therapy of disseminated intravascular coagulation]. Hamatologie und Bluttransfusion, 1970, Volume: 9 Topics: Abortion, Septic; Adolescent; Adult; Anticoagulants; Antithrombins; Blood; Blood Coagulation Disorders; Blood Coagulation Factors; Child; Disseminated Intravascular Coagulation; Encephalitis; Encephalitis Viruses; Female; Fibrin; Fibrinogen; Fibrinolysis; Hemorrhagic Disorders; Humans; Liver; Male; Necrosis; Pituitary Gland; Pregnancy; Prostatic Neoplasms; Prothrombin; Sepsis; Shock, Septic; Spleen; Streptokinase	1970
Heparin in the treatment of hemorrhagic diathesis associated with prostatic carcinoma. The Journal of urology, 1969, Volume: 102, Issue:2 Topics: Aged; Blood Coagulation; Blood Coagulation Factors; Fibrinogen; Hemorrhagic Disorders; Heparin; Humans; Male; Neoplasm Metastasis; Prostatic Neoplasms	1969
Hemorrhagic syndrome following transurethral prostatic resection for benign adenoma. Archives of internal medicine, 1969, Volume: 124, Issue:3 Topics: Adenoma; Aged; Blood Coagulation Disorders; Blood Coagulation Tests; Fibrinogen; Fibrinolysis; Hematuria; Heparin; Humans; Male; Postoperative Complications; Prostatectomy; Prostatic Neoplasms; Urethra	1969
[Fibrinogen-I-131 uptake by prostatic tissue in man]. Atti della Accademia dei fisiocritici in Siena. Sezione medico-fisica, 1964, Volume: 13, Issue:1 Topics: Adult; Aged; Fibrinogen; Humans; Iodine Radioisotopes; Male; Middle Aged; Prostatic Neoplasms	1964